|  
Home
Provigil Information
A Solution for Sleepiness
Taking Provigil
Off-Label Provigil
Use
Journal Articles
Related Resources
Provigil in the News
About Provigil Web
|
 |
 |
 |

J Pharmacol Exp Ther. 2006 Nov;319(2):561-9. Epub 2006 Aug
Modafinil occupies dopamine and norepinephrine transporters in vivo
and modulates the transporters and trace amine activity in vitro
Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R,
Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ.
Department of Psychiatry, Harvard Medical School, New England Primate
Research Center
2-[(Diphenylmethyl) sulfinyl]acetamide (modafinil), prescribed principally
to treat narcolepsy, is undergoing assessment for other neuropsychiatric
disorders and medical conditions. The neurochemical substrates of modafinil
are unresolved. We postulated that modafinil enhances wakefulness by modulating
dopamine (DAT), norepinephrine (NET), or serotonin (SERT) transporter
activities. In vivo, we determined DAT and NET occupancy by modafinil
by positron emission tomography imaging; in vitro, we determined modafinil
activity at the DAT, NET, SERT, and rhesus monkey trace amine receptor
1 (TA1). In rhesus monkey, modafinil occupancy of striatal DAT was detected
by [(11)C]2beta-carbomethoxy-3beta-4-(fluorophenyl)tropane and of thalamic
NET by [(11)C](S,S)-2-(alpha-(2-methoxyphenoxy)-benzyl)morpholine. In
vitro, modafinil effects in DAT-human embryonic kidney (HEK), NET-HEK,
and SERT-HEK cells were investigated alone or combined with the TA1 receptor.
Modafinil (i.v.) occupied striatal DAT sites (5 mg/kg: 35 +/- 12%, n =
4; 8 mg/kg: 54 +/- 3%, n = 3). In thalamus, modafinil occupied NET sites
(5 mg/kg: 16 +/- 7.8%, n = 6; 8 mg/kg: 44 +/- 12%; n = 2). In vitro, modafinil
inhibited [(3)H]dopamine (IC(50) = 6.4 microM), [(3)H]norepinephrine (IC(50)
= 35.6 microM), and [(3)H]serotonin (IC(50) > 500 microM) transport
via the human DAT, NET, and SERT. Modafinil did not activate the TA1 receptor
in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement
of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but
not in TA1-SERT cells. The present data provide compelling evidence that
modafinil occupies the DAT and NET in living brain of rhesus monkeys and
raise the possibility that modafinil affects wakefulness by interacting
with catecholamine transporters in brain.
|
|